PEMDOTLS: Preclinical evaluation of Miltefosin derivatives optimised for the treatment of Leishmaniasis and Sleep Disease. (Q2906826): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in pt, en, fr, de, nl, it, es, et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, da, ro, sv, and other parts: Adding translations: et, lt, it, fr, hr, el, en, sk, fi, pl, hu, nl, cs, lv, ga, sl, es, bg, mt, pt, da, ro, de, sv,) |
(Changed label, description and/or aliases in en, pt: Fixing missing labels.) |
||
| label / pt | label / pt | ||
PEMDOTLS .: Avaliação pré-clínica de derivados da Miltefosina otimizados para o tratamento da Leishmaniose e Doença do Sono. | |||
| label / en | label / en | ||
PEMDOTLS: Preclinical evaluation of Miltefosin derivatives optimised for the treatment of Leishmaniasis and Sleep Disease. | |||
Revision as of 11:06, 23 August 2022
Project Q2906826 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PEMDOTLS: Preclinical evaluation of Miltefosin derivatives optimised for the treatment of Leishmaniasis and Sleep Disease. |
Project Q2906826 in Portugal |
Statements
204,000.0 Euro
0 references
240,000.0 Euro
0 references
85.0 percent
0 references
26 July 2018
0 references
25 July 2022
0 references
INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR - IBMC
0 references
Q2985732 (Deleted Item)
0 references
41°8'58.02"N, 8°36'38.84"W
0 references
Porto
0 references
Identifiers
POCI-01-0145-FEDER-031013
0 references